Press release -

Biosensor- Attana Cell 200, label free, real time kinetics on cells

Attana AB introduces the Attana Cell 200 – the first system to permit real-time kinetic analysis of molecular interactions directly on cell surfaces, bringing drug development a step closer to the body.

As the first company in the world, Attana launches a system measuring molecular interactions label free directly on cell surfaces. In line with Attana’s innovative strategy, the Attana Cell 200 is a revolutionary system that rapidly generates biologically relevant information on molecular interactions with cell surfaces. Thanks to groundbreaking innovations and sedulous developments, Attana is the only player on the market that offers cells integrated as sensor surface. The experiments mimic real life conditions and generate information with higher biological relevance in comparison with traditional synthetic sensor surfaces.

Drug development is financially risky and time consuming. To save money and time the industry needs to early identify and eliminate unsuitable candidates. Attana Cell 200 biosensor system improves the selection process by rapidly identifying promising drug candidates. This enables early and well informed decisions in selecting relevant candidates while reducing unnecessary development costs and saving time. The Attana Cell 200 is label free, can run unpurified candidate molecules and has high throughput, resulting in fast and efficient screening of many drug candidates.

Attana Cell 200 is launched with new applications such as kinetic evaluation of cellular biomolecular interactions, e.g. antibody-receptor and lectin-carbohydrate, competition assays and cell capturing.

For more information, please contact Gabriela Suhoschi, Marketing Manager, Attana AB: gabriela.suhoschi@attana.com, +46 (0) 8- 674 57 12 or visit our web:www.attana.com

For press release in Swedish please see attached document.

Topics

  • Health, Health Care, Pharmaceuticals

Categories

  • biosensor
  • label free
  • real time
  • kinetic on cells
  • attana cell 200
  • attana
  • qcm

About Attana AB

Based in Stockholm, Sweden, Attana AB develops and sells biosensors for analysis of biomolecular interactions. Our systems have since 2003 been employed at leading life science companies and universities worldwide, working in a wide variety of research fields. Attana’s biosensors can be used to determine specificity, kinetics and affinity, amongst other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.

Related content

  • Attana highlighted in Today in America with Terry Bradshaw

    March 3rd, 2011, Stockholm, Sweden – Attana AB, developer of biosensors, is proud to announce our participation in Today in America with Terry Bradshaw in their series on topics, trends, and issues related to “Improving Diagnostic Outcomes through Biosensor Technology” as part of the show’s “Medical Minutes” series.

  • Characterisation of complex lectin-cell kinetics (Attana Application Example)

    Attana Cell 200 - Label free, real time kinetics on cells, exploring biology on a new level!
     
    In the development process of new pharmaceutical compounds, kinetic experiments provide insights
    into potential drug candidates while also defining lead targets. In this application example we demonstrate the ability of the Attana Cell™ 200 to provide a complete and highly relevant analysis of a

  • PEGS 2011 with Attana!

    We are pleased to have met so many like minded members of industry during the Protein Engineering Summit 2011 in Boston last week. If you were there but didn't get the chance to taste our exquisite espresso you are always welcome to stop by our booth during our upcoming events!

  • Attana appears in Swedish Life Science

    "Swedish Life Science is a comprehensive introduction to an industry that employs some 40,000 people in Sweden, accounts for 20 per cent of Swedish net export worth over over SEK 40 billion, and is fast becoming a cornerstone of the national economy."

  • Find out: Why bridge the existing gap between biochemical and cell based assays?

    One efficient tool in the selection process is biochemical label‐free kinetic characterisation of interactions between candidate and target molecules. Information on association and dissociation rates and affinity is provided under purified conditions. However, the results obtained are often different compared to the affinity results obtained with cell based methods.

  • A New Generation of Cell-Biosensors targeting Cancer

    Read the latest article in IPT (Innovations in Pharmaceutical Technology) about the new generation cell-biosensors that enables studies in a more relevant cellular environment to better understand drug-cell interactions for development of new pharmaceuticals. A model like this using bio-sensors could significantly reduce the costs and time-scales involved in the development of the next generation

  • PEGS 2010 with Attana!

    We are happy to have met so many industry people during the Protein Engineering Summit 2010 in Boston last week, and if you were there but didn't get the chance to taste our exquisite espresso you are welcome to stop by our booth during our upcoming events!

  • Attana's Story told by CEO and co-founder Dr. Teodor Aastrup

    When we founded Attana in 2002, we had a dream of creating a tool that could mimic reality. We were set to do this by developing an instrument capable of measuring biological interactions exactly as the actual events in the human body.

  • German inauguration with Attana 200 biosensor!

    Attana appears in Dresdner Neueste Nachrichten, a regional German newspaper in association with the inauguration of the new “B CUBE” research labs of the Technische Universität Dresden. The new research labs are part of a large regional German investment for scientific research and innovative technologies. The Attana 200 appears here as one of B CUBE’s innovative biosensor technologies

  • Tecan Journal- corporate news!

    Find out latest news, events and collaborations from Tecan- read the interview with Attana's Sales and Marketing Manager, Gabriela Suhoschi about Attana's collaboration with Tecan's on page 5!

  • A film crew, cameras and biosensors!

    Recently a film crew visited the Attana office to prepare our participation on Terry Bradshaw’s “Today in America” show. Their research team had heard about our ground breaking cell based biosensor and asked us to participate on the show. The days before the filming were filled with intense preparation, and consequently on the day of shooting everything went smoothly..

  • Biotech companies - Ways to work more efficiently

    Ernst & Young recently released their 24th annual report Beyond borders: global biotechnology report 2010, presenting, among other things, five guiding principles for biotech companies working in the new economy where funding is scarce and customers careful:

  • Universities and Innovation

    We consider it strategically important to keep collaborating with our customers, university researchers in particular, to stay on top and keep getting inspired.

Related events